Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest drug discovery Stories

2014-03-16 23:01:05

Laboratory automation is defined as the use of technology to streamline or substitute manual manipulation of equipment and processes. http://www.marketsandmarkets.com/Market-Reports/lab-automation-market-1158.html (PRWEB) March 16, 2014 The "Lab Automation Market by Equipment and Software (Automated Liquid Handling and Robotics, Microplate Readers, LIMS and Automated Storage), and Applications (Drug Discovery, Clinical Diagnostics, Genomics, Proteomics) - Trends and Global Forecasts...

2014-03-16 23:00:43

Purdue University and Houston Methodist Research Institute plan to collaborate on research and educational initiatives, including clinical trials of drugs developed at Purdue. West Lafayette, IN (PRWEB) March 16, 2014 Purdue University and Houston Methodist Research Institute plan to collaborate on research and educational initiatives, including clinical trials of drugs developed at Purdue. The partnership helps to advance the Purdue Moves drug discovery initiative to translate basic...

2014-03-13 08:28:52

Overall Survival Data from the HEAT Study Supports Continued Clinical Development of ThermoDox in Primary Liver Cancer LAWRENCEVILLE, N.J., March 13, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the year ended December 31, 2013, and provided an update on its clinical trials of ThermoDox®, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin. ThermoDox is being...

2014-03-12 12:28:20

BETHESDA, Md., March 12, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today refuted false statements and material distortions made by Adam Feuerstein in an article on Tuesday, March 11. http://photos.prnewswire.com/prnvar/20110329/SF73084LOGO Feuerstein falsely accused NW Bio of manipulating its news by delaying announcement of the Hospital Exemption...

2014-03-11 23:02:02

Partnership with DIA to Honor People Who Give the Gift of Participation in Clinical Research BOSTON, MA (PRWEB) March 11, 2014 The Center for Information and Study on Clinical Research Participation (CISCRP), an independent non-profit, is excited to announce the launch of a new event -- Medical Heroes Appreciation 5K Run & Walk in San Diego -- to celebrate the volunteers who give the gift of participation in clinical research. The first annual Medical Heroes Appreciation 5K Run &...

Detailed Picture Of Protein Linked To Learning, Pain And Brain Disorders Created By Scientists
2014-03-07 11:26:29

Scripps Research Institute Researchers at The Scripps Research Institute (TSRI) and Vanderbilt University have created the most detailed 3-D picture yet of a membrane protein that is linked to learning, memory, anxiety, pain and brain disorders such as schizophrenia, Parkinson's, Alzheimer's and autism. "This receptor family is an exciting new target for future medicines for treatment of brain disorders," said P. Jeffrey Conn, PhD, Lee E. Limbird Professor of Pharmacology and director...

2014-03-06 23:26:16

MarketReportsOnline.com adds "Europe Orphan Drug Market Outlook 2018" report to its research store. Dallas, Texas (PRWEB) March 06, 2014 Purchase the report for 20% discount. Offer valid until 31st March 2014. The orphan drugs enjoy significant competitive advantages in the market owing to the market exclusivity period after the drug has been authorized. Through this clause, the manufacturer of orphan drugs is given a monopoly status in the market because according to the law,...

2014-03-06 23:25:21

Independent Biomedical Research Firm Unites Science and Personalized Medicine For Patient-driven and Goal-oriented Applied Aging Research Baltimore, MD (PRWEB) March 06, 2014 In Silico Medicine Inc, developing novel computer-assisted methods for drug discovery in aging research, has officially launched in the US. In Silico Medicine draws on years of research and software development expertise of its partner, Pathway Pharmaceuticals in Hong Kong, which employs its state of the art...

2014-03-05 08:28:45

Publication Further Validates Lpath's Approach to Targeting Bioactive Lipids for Drug Discovery SAN DIEGO, March 5, 2014 /PRNewswire/ -- Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, has brought scientists one step closer to finding a potential treatment for traumatic brain injury (TBI) with a recent publication showing that Lpathomab(TM), a therapeutic antibody, reverses much of the damage caused by trauma to the nervous system. As...

2014-03-04 08:32:04

SAN DIEGO, March 4, 2014 /PRNewswire/ -- Absorption Systems, a global leader in preclinical contract testing of drugs, biologics, and medical devices, is pleased to announce that Dr. Glenwood Gum, Associate Director, Preclinical Operations, will present a talk at the 6(th) Ocular Diseases & Drug Discovery Conference on March 20(th) in San Diego. The title of his presentation is "Developing Predictive Preclinical Models for Novel Anterior Segment Drug Delivery." The conference,...